This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Katapadi, K. Articles by Kostandy, G. Search for Related Content PubMed PubMed Citation Articles by Katapadi, K. Articles by Kostandy, G. Social Bookmarking                         What's this?

A Review of Erythromycin-Induced Malignant Tachyarrhythmia— Torsade de Pointes

A Case Report

G. Kostandy

M. Katapadi

K.M.A. Hussain

D. Schifter

G. Kostandy, MD

Medical Director of South Brooklyn Health Center Affiliated with New York Methodist Hospital 120 Richards Street Brooklyn, NY 11213

The term torsade de pointes refers to a ventricular tachycardia characterized by QRS complexes of changing amplitude that appears to twist around the isoelectric line and occurs at rates of 200-250/minute. Most cases of torsade de pointes are iatrogenically induced by drugs or electrolyte abnormalities. The most important feature is QT interval prolongation. Torsade de pointes was first described in 1966 in France by Dessertenne.

The authors report a case of a fifty-year-old woman with medical history of corrective surgery for tetralogy of Fallot who was admitted to the hospital with pneumonia and atrial fibrillation and later developed recurrent episodes of polymorphic ventricular tachy cardia with QT interval prolongation after IV administration of erythromycin. The episodes did not recur after discontinuation of erythromycin, and the QT interval returned to normal. The association of erythromycin with torsade de pointes has been reported in 18 cases to date. Erythromycin has been shown to produce electrophysio logic effects similar to those of class Ia and class III antiarrhythmic drugs on the cardiac muscle.

This potentially fatal complication of a commonly used antibiotic is rare, but increased physician awareness is important, especially in patients with predisposing factors like electrolytes abnormalities, use of class Ia and Class III antiarrhythmic drugs, and presence of prolonged QT interval (congenital prolonged QT syndromes). This is the second case reported in a patient with previous cardiac surgery and erythromycin administration.

Angiology, Vol. 48, No. 9, 821-826 (1997)
DOI: 10.1177/000331979704800909


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?